Literature DB >> 2371060

Meibomian gland dysfunction: some clinical, biochemical and physical observations.

B L Ong1, J R Larke.   

Abstract

Dysfunction of the meibomian glands resulting from contact lens wear has recently been recognized. This study shows that 30% of lens wearers develop some degree of meibomian gland dysfunction after 6 months of wear whereas only 20% of non-lens wearers have similar problem. Thirty-three per cent of the male wearers have dysfunctioning glands compared with 28% of female wearers. The incidence does not depend on the type of lenses worn. There was no detectable differences between the composition of the abnormal fluid secreted by the dysfunctioning glands and the clear fluid coming out of the normal unblocked glands, as shown by thin layer chromatography. On studying the melting point of the lipids, we found that material from abnormal glands melted at approximately 3 degrees C higher than the normal fluid.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2371060     DOI: 10.1111/j.1475-1313.1990.tb00968.x

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  24 in total

1.  Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study.

Authors:  Gary N Foulks; Douglas Borchman; Marta Yappert; Shelley Kakar
Journal:  Cornea       Date:  2013-01       Impact factor: 2.651

Review 2.  Meibocyte differentiation and renewal: Insights into novel mechanisms of meibomian gland dysfunction (MGD).

Authors:  Ho Sik Hwang; Geraint J Parfitt; Donald J Brown; James V Jester
Journal:  Exp Eye Res       Date:  2017-02-17       Impact factor: 3.467

3.  [Meibomian glands : part IV. Functional interactions in the pathogenesis of meibomian gland dysfunction (MGD)].

Authors:  E Knop; N Knop
Journal:  Ophthalmologe       Date:  2009-11       Impact factor: 1.059

Review 4.  The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee.

Authors:  Alan Tomlinson; Anthony J Bron; Donald R Korb; Shiro Amano; Jerry R Paugh; E Ian Pearce; Richard Yee; Norihiko Yokoi; Reiko Arita; Murat Dogru
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 5.  The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD.

Authors:  Debra A Schaumberg; Jason J Nichols; Eric B Papas; Louis Tong; Miki Uchino; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 6.  The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland.

Authors:  Erich Knop; Nadja Knop; Thomas Millar; Hiroto Obata; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

7.  Topical azithromycin therapy for meibomian gland dysfunction: clinical response and lipid alterations.

Authors:  Gary N Foulks; Douglas Borchman; Marta Yappert; Sung-Hye Kim; John W McKay
Journal:  Cornea       Date:  2010-07       Impact factor: 2.651

8.  Effects of age and dysfunction on human meibomian glands.

Authors:  Chyong Jy Nien; Salina Massei; Gloria Lin; Cameron Nabavi; Jeremiah Tao; Donald J Brown; Jerry R Paugh; James V Jester
Journal:  Arch Ophthalmol       Date:  2011-04

9.  The optimum temperature for the heat therapy for meibomian gland dysfunction.

Authors:  Douglas Borchman
Journal:  Ocul Surf       Date:  2019-02-19       Impact factor: 5.033

10.  The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis).

Authors:  Marian S Macsai
Journal:  Trans Am Ophthalmol Soc       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.